Cargando…
Sensitivity of Mycobacterium leprae to Telacebec
The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis(.) The unprecedented potency of Telacebec against M. leprae...
Autores principales: | Lahiri, Ramanuj, Adams, Linda B., Thomas, Sangeeta Susan, Pethe, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888226/ https://www.ncbi.nlm.nih.gov/pubmed/35202539 http://dx.doi.org/10.3201/eid2803.210394 |
Ejemplares similares
-
Mycobacterium leprae Transcriptome During In Vivo Growth and Ex Vivo Stationary Phases
por: Ojo, Olabisi, et al.
Publicado: (2022) -
Semi-automated protocol for purification of Mycobacterium leprae from tissues using the gentleMACS™ Octo Dissociator
por: Williams, Diana L., et al.
Publicado: (2014) -
Nitazoxanide is active against Mycobacterium leprae
por: Bailey, Mai Ann, et al.
Publicado: (2017) -
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
por: Chauffour, Aurélie, et al.
Publicado: (2020) -
Mycobacterium leprae Infection in Ticks and Tick-Derived Cells
por: Tongluan, Natthida, et al.
Publicado: (2021)